Clinical Trial Update: A Study of EDP-305 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study assessing EDP-305 in subjects with mild to moderate hepatic impairment versus healthy volunteers in the context of nonalcoholic steatohepatitis (N…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• EDP-305

Snippet

Sponsor: Enanta Pharmaceuticals, Inc | Conditions: NASH | Phase 1 | Status: COMPLETED